3 'Perfect 10' Stocks That Have Legs for Future Gains
| |
| Biotech is a fickle sector for stock investors. These companies are notorious for their extraordinary overhead expenses and their high-cost operations. Until, that is, they hit their corporate jackpot and get approval on a novel new drug, or a first-in-class treatment, or corner the market in the treatment of a rare or terminal condition. When that happens, investors can see their holdings appreciate by leaps and bounds. The gains in the NASDAQ IBB demonstrate this possibility; this index of NASDAQ biotech stocks is up 33% in the past 52 weeks... Read the full article... |
 |
| |
| | | Download Our Award Winning Apps | | | |
| |
| |
| |
Disclaimer:
Fusion Media or anyone involved with Fusion Media will not accept any liability for any trading loss or damage as a result of reliance on the information contained within this email including data, quotes, charts and buy/sell signals. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. Fusion Media would like to remind you that the data contained in this email is neither necessarily real-time nor accurate. All stock prices, Indexes, Futures, buy/sell Signals and Forex prices are indicative and not appropriate for trading purposes; furthermore they are not provided by an exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price. Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
This is a newsletter from Investing.com
© 2007-2020 Fusion Media Limited. All Rights Reserved
7 Florinis Street, Greg Tower 6th Floor Nicosia 1065 Cyprus
| | Terms And Conditions | Privacy Policy | Manage your e-mail preferences | Unsubscribe | | This email was sent to o354397655@gmail.com | |
 |
沒有留言:
張貼留言